Oruka Therapeutics stockORKA
Oruka Therapeutics trades at $96.02, 16.9% below its 52-week high (Aug 19, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +216.8% year to date, +251.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 18, 2026.
Ratings, candles, signals and the screener for ORKA — after you log in
Open the terminalFrequently asked questions about Oruka Therapeutics
What is the Oruka Therapeutics stock price?
At the close on Nov 5, 2026: $96.02 (−5.32% on the day). 52-week high: $115.52 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Oruka Therapeutics report earnings?
The next quarterly report is on Nov 18, 2026. Last quarter, earnings per share changed −20% year over year, revenue 0%.
Does Oruka Therapeutics pay dividends?
No, Oruka Therapeutics does not pay dividends.
Where does Oruka Therapeutics trade and how to buy it?
Ticker ORKA, exchange Nasdaq, listed since 1997. You can buy it through a broker with access to US exchanges.
Should I buy Oruka Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ORKA are in the terminal after you log in.